Thomas Andrew Crockett

Insider Reports History

Location
Wiltshire, United Kingdom
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Andrew Crockett:

Company Role Class Num Shares Value Price $ Report Date Ownership
KalVista Pharmaceuticals, Inc. CEO, Director Common Stock 211,203 $2,981,088 $14.11 20 Feb 2024 Direct
KalVista Pharmaceuticals, Inc. CEO, Director Performance Stock Units 62,500 $938,081 $15.01 17 Feb 2024 Direct
KalVista Pharmaceuticals, Inc. CEO, Director Restricted Stock Unit 48,612 $729,632 $15.01 17 Feb 2024 Direct
KalVista Pharmaceuticals, Inc. CEO, Director Performance Stock Unit 0 $8.23 17 Nov 2023 Direct

Insider Reports Filed by Thomas Andrew Crockett

Symbol Company Period Transactions Value $ Form Type Role Filing Time
KALV KalVista Pharmaceuticals, Inc. 17 Feb 2024 6 -$351,289 4 CEO, Director 21 Feb 2024, 21:41
KALV KalVista Pharmaceuticals, Inc. 14 Feb 2024 1 -$875,883 4 CEO, Director 16 Feb 2024, 16:20
KALV KalVista Pharmaceuticals, Inc. 11 Feb 2024 2 $0 4 CEO, Director 13 Feb 2024, 09:08
KALV KalVista Pharmaceuticals, Inc. 01 Feb 2024 2 -$162,198 4 CEO, Director 05 Feb 2024, 17:55
KALV KalVista Pharmaceuticals, Inc. 27 Dec 2023 1 -$360,453 4 CEO, Director 28 Dec 2023, 16:28
KALV KalVista Pharmaceuticals, Inc. 17 Nov 2023 5 -$121,851 4 CEO, Director 21 Nov 2023, 16:30
KALV KalVista Pharmaceuticals, Inc. 30 Oct 2023 1 $0 4 CEO, Director 01 Nov 2023, 16:12
KALV KalVista Pharmaceuticals, Inc. 17 Aug 2023 5 -$159,602 4 CEO, Director 21 Aug 2023, 20:05
KALV KalVista Pharmaceuticals, Inc. 17 Feb 2023 1 $0 4/A CEO, Director 22 May 2023, 21:36
KALV KalVista Pharmaceuticals, Inc. 11 Jan 2023 5 -$57,083 4 CEO, Director 19 May 2023, 21:17
KALV KalVista Pharmaceuticals, Inc. 17 Nov 2022 3 -$9,710 4 CEO, Director 21 Nov 2022, 15:17
KALV KalVista Pharmaceuticals, Inc. 02 Sep 2022 2 -$22,458 4 CEO, Director 07 Sep 2022, 16:50
KALV KalVista Pharmaceuticals, Inc. 17 Aug 2022 3 -$26,890 4 CEO, Director 19 Aug 2022, 16:58
KALV KalVista Pharmaceuticals, Inc. 17 May 2022 2 $0 4 CEO, Director 19 May 2022, 16:55
KALV KalVista Pharmaceuticals, Inc. 09 Mar 2022 1 -$170,693 4 CEO, Director 11 Mar 2022, 15:56
KALV KalVista Pharmaceuticals, Inc. 01 Oct 2021 1 -$171,841 4 CEO, Director 04 Oct 2021, 16:57
KALV KalVista Pharmaceuticals, Inc. 01 Jul 2021 2 -$241,477 4 CEO, Director 02 Jul 2021, 17:35
KALV KalVista Pharmaceuticals, Inc. 17 Jun 2021 1 -$32,051 4 CEO, Director 22 Jun 2021, 17:15
KALV KalVista Pharmaceuticals, Inc. 09 Jun 2021 1 -$268,480 4 CEO, Director 11 Jun 2021, 19:29
KALV KalVista Pharmaceuticals, Inc. 26 May 2021 2 $0 4 CEO, Director 28 May 2021, 17:23